A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/12 (2006.01) A61P 7/00 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01) A61P 35/00 (2006.01) C07K 7/50 (2006.01)
Patent
CA 2543630
The use of a compound of formula (I): in a method of manufacturing a medicament for the treatment or prophylaxis of a condition wherein inhibition of carboxypeptidase U is beneficial; specified compounds of formula (I) and compositions comprising a compound of formula (I) and a pharmaceutically acceptable adjuvant, diluent or carrier.
L'invention concerne l'utilisation d'un composé de formule (I): dans un procédé de fabrication d'un médicament destiné au traitement ou à la prophylaxie d'un état pour lequel l'inhibition de la carboxypeptidase U est bénéfique; des composés spécifiés de formule (I) et des compositions renfermant un composés de formule (I), ainsi qu'un adjuvant, un diluent ou un excipient acceptable sur le plan pharmaceutique.
Bjoerquist Petter
Buchanan Malcolm
Campitelli Marc
Carroll Anthony
Hyde Edward
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Use of cyclic anabaenopeptin-type peptides for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cyclic anabaenopeptin-type peptides for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cyclic anabaenopeptin-type peptides for the treatment... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2084471